Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Essentials of the adult neurogenic bladder / / edited by Jacques Corcos, Gilles Karsenty, Thomas Kessler, David Ginsberg
| Essentials of the adult neurogenic bladder / / edited by Jacques Corcos, Gilles Karsenty, Thomas Kessler, David Ginsberg |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Boca Raton : , : CRC Press, , 2021 |
| Descrizione fisica | 1 online resource (363 pages) |
| Disciplina | 616.62 |
| Soggetto topico | Neurogenic bladder |
| ISBN |
1-000-09138-4
1-000-09134-1 0-429-32067-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Half Title -- Title Page -- Copyright Page -- Contents -- Foreword -- Contributors -- Introduction -- Part 1: Epidemiology and Pathophysiology of Neurogenic Bladders -- Chapter 1: Epidemiology of Neurogenic Bladder -- Chapter 2: Pathophysiology of Detrusor Overactivity -- Chapter 3: Pathophysiology of Detrusor Underactivity/Acontractile Detrusor -- Chapter 4: Pathophysiology of the Low Compliant Bladder -- Chapter 5.: Pathophysiology and Prevalence of Detrusor-Sphincter Dyssynergia -- Chapter 6: Pathophysiology of Autonomic Dysreflexia -- Chapter 7: Pathophysiology of Spinal Shock -- Part II: Neurologic Pathologies Responsible for the Development of the Neurogenic Bladder -- Section A: Peripheral Neuropathies -- Chapter 8: Systemic Illnesses (Diabetes Mellitus, Sarcoidosis, Alcoholism, and Porphyrias) -- Chapter 9: Peripheral Neuropathies of the Lower Urinary Tract Following Pelvic Surgery and Radiation Therapy -- Section B: Hereditary and Degenerative Diseases -- Chapter 10: Dementia and Lower Urinary Tract Dysfunction -- Chapter 11: Pathologies of the Basal Ganglia, such as Parkinson.'.s and Huntington.'.s Diseases -- Section C: Demyelinating Neuropathies -- Chapter 12: Multiple Sclerosis, Transverse Myelitis, Tropical Spastic Paraparesis, Progressive Multifocal Leukoencephalopathy, Lyme Disease -- Section D: Vascular Pathologies and Tumors of the Brain Presents -- Chapter 13: Cerebrovascular Accidents, Intracranial Tumors, and Voiding Dysfunction -- Section E: Disk Prolapse And Tumors Of The Spinal Cord -- Chapter 14: Tumors of the Spine, Intervertebral Disk .Prolapse, the Cauda Equina Syndrome -- Chapter 15: Tethered Cord Syndrome -- Section F: Traumatic Injuries of the Central Nervous System -- Chapter 16: Spinal Cord Injury and Cerebral Trauma -- Section G: Other Neurologic Pathologies Responsible for Neurogenic Bladder Dysfunction.
Chapter 17: Cerebral Palsy, Cerebellar Ataxia, AIDS, Phacomatosis, Neuromuscular Disorders, and Epilepsy -- Chapter 18: Syringomyelia and Lower Urinary Tract Dysfunction -- Part III: Evaluation of Neurogenic Bladder Dysfunction -- Chapter 19: Considerations for the Focused Neuro-Urologic History and Physical Exam -- Chapter 20: Patient-Reported Outcome Measures in Neurogenic Bladder -- Chapter 21: Endoscopic Evaluation of Neurogenic Bladder -- Chapter 22: Evaluation of Neurogenic Lower Urinary Tract Dysfunction -- Chapter 23: Electrophysiologic Evaluation -- Chapter 24: Neuroimaging in the Evaluation of Neurogenic Bladder Dysfunction -- Chapter 25: Practical Guide to Diagnosis and Follow-up of Patients with Neurogenic Bladder Dysfunction -- Part IV: Classification -- Chapter 26: Classification of Lower Urinary Tract Dysfunction -- Part V: Treatment -- Chapter 27: Conservative Treatment -- Chapter 28: Systemic, Intrathecal, and Intravesical Pharmacologic Treatment of Neurogenic Lower Urinary Tract Dysfunction -- Chapter 29: Management of Autonomic Dysreflexia -- Chapter 30: Peripheral and Intravesical Electrical Stimulation of the Bladder to Restore Bladder Function -- Chapter 31: Surgery to Improve Reservoir Function -- Chapter 32: Surgery to Improve Bladder Outlet Function -- Chapter 33: Urinary Diversion -- Chapter 34: Transappendicular Continent Cystostomy Technique (Mitrofanoff Principle) -- Chapter 35: Tissue Engineering and Cell Therapies for Neurogenic Bladder Augmentation and Urinary Continence Restoration -- Chapter 36: Neuroprotection and Repair after Spinal Cord Injury -- Chapter 37: Neural Rerouting in Patients with Spinal Cord Injury -- Part VI: Synthesis of Treatment -- Chapter 38: An Overview of Treatment Alternatives for Different Types of Neurogenic Bladder Dysfunction in Adults -- Part VII: Complications. Chapter 39: Complications Related to Neurogenic Bladder Dysfunction I -- Chapter 40: Complications Related to Neurogenic Bladder Dysfunction II -- Chapter 41: Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Men with Neurogenic Bladder -- Part VIII: Sexual dysfunction and reproduction in neurologic disorders -- Chapter 42: Pathophysiology of Male Sexual Dysfunction after Spinal Cord Injury -- Chapter 43: Treatment Modalities for Erectile Dysfunction in Neurologic Patients -- Chapter 44: Fertility Issues in Men with Spinal Cord Injury -- Chapter 45: Pregnancy in Spinal Cord Injury -- Part IX: Prognosis and Follow-up -- Chapter 46: Prognosis of Neurogenic Bladders -- Part X: Neurogenic Bladders in Developing Countries -- Chapter 47: Challenges of Management of Neurogenic Bladder in THE Developing World -- Part XI: References for Reports and guidelines -- Chapter 48: Reports and Guidelines in Relation to Neurogenic Bladder Dysfunction -- Index. |
| Record Nr. | UNINA-9910860837803321 |
| Boca Raton : , : CRC Press, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Overactive bladder : practical management / / edited by Jacques Corcos, Scott MacDiarmid, John Heesakkers
| Overactive bladder : practical management / / edited by Jacques Corcos, Scott MacDiarmid, John Heesakkers |
| Pubbl/distr/stampa | Chichester, West Sussex, United Kingdom ; ; Hoboken, New Jersey : , : John Wiley & Sons, , 2015 |
| Descrizione fisica | 1 online resource (272 p.) |
| Disciplina | 616.6/2 |
| Soggetto topico |
Urinary incontinence - Treatment
Bladder - Diseases - Treatment |
| ISBN |
1-118-64058-6
1-118-64056-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title Page; Copyright Page; Contents; Contributors; Foreword; Foreword: The impact of Overactive Bladder on Urogynecology; Foreword; Preface; Section 1 Introduction; Chapter 1 Overactive bladder: terminology and problem spectrum; References; Chapter 2 Pathophysiology; Introduction; The innervation of the bladder; The genesis of the NDO: three hypothesis; The link to the clinic; The neurological pathologies responsible for the development of the neurogenic bladder; Histological changes; Conclusions; References; Section 2 Evaluation; Chapter 3 Timing for evaluation; Conclusion; References
Chapter 4 Clinical evaluation Introduction; History; Neurological history; General gynecological history; Obstetric history; Other relevant past medical and surgical history; Drug history; Examination; Questionnaires and quality of life; Summary; References; Chapter 5 Urodynamic evaluation of the overactive bladder; Introduction; OAB and urodynamics; Filling cystometry and OAB; Cystometrogram; Does OAB equal urodynamic DO? A clinical correlation; Pressure-flow studies and OAB; Summary; References; Chapter 6 Other testing; Bladder/detrusor wall thickness; Biomarkers; Near infrared spectroscopy Bladder wall strain imaging Autonomic nervous system; Functional brain imaging; Conclusions; References; Section 3 First Line Management; Chapter 7 Changes in lifestyle; Introduction; Lifestyle modifications; Obesity; Smoking; Extremes of daily fluid intake; Dietary bladder irritants; Constipation and straining at stool; Summary; References; Patient Guide 1 Lifestyle changes that can improve bladder symptoms; Maintain a healthy weight; Stop smoking; Moderate liquid and beverage intake; Monitor your diet; Maintain bowel regularity; Chapter 8 Physical therapy; Physical therapy Scheduled voiding/bladder training Pelvic floor muscle training; Electrical stimulation; References; Section 4 Second Line Management; Chapter 9 Oral medication for overactive bladder; Introduction; Antimuscarinics; Beta 3 (β3) adrenergic receptor (AR) agonists; Antidepressants; References; Chapter 10 Patches and gels; Rationale for TD OXY delivery; Drug pharmacology; Conclusion/expert opinion; References; Chapter 11 Promising experimental drugs and drug targets; Introduction; P2X3-receptors and P2X3 receptor antagonists; The cannabinoid system; TRP channels; References Chapter 12 The role of co-medication in the treatment of OAB Introduction; Antimuscarinics and α-adrenoreceptor antagonists; Phosphodiesterase-5 inhibitors and α-adrenoreceptor antagonists; Other combination regimens; Future directions; References; Chapter 13 Other non-surgical approaches for the treatment of overactive bladder; Introduction; Bladder training; Acupuncture; Naturopathic and herbal remedies; Magnetic stimulation; Containment products; Future: tissue engineering and gene therapy; Conclusion; Abbreviations; Financial and competing interests disclosure; References Section 5 Third Line Management |
| Record Nr. | UNINA-9910140462003321 |
| Chichester, West Sussex, United Kingdom ; ; Hoboken, New Jersey : , : John Wiley & Sons, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Overactive bladder : practical management / / edited by Jacques Corcos, Scott MacDiarmid, John Heesakkers
| Overactive bladder : practical management / / edited by Jacques Corcos, Scott MacDiarmid, John Heesakkers |
| Pubbl/distr/stampa | Chichester, West Sussex, United Kingdom ; ; Hoboken, New Jersey : , : John Wiley & Sons, , 2015 |
| Descrizione fisica | 1 online resource (272 p.) |
| Disciplina | 616.6/2 |
| Soggetto topico |
Urinary incontinence - Treatment
Bladder - Diseases - Treatment |
| ISBN |
1-118-64058-6
1-118-64056-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title Page; Copyright Page; Contents; Contributors; Foreword; Foreword: The impact of Overactive Bladder on Urogynecology; Foreword; Preface; Section 1 Introduction; Chapter 1 Overactive bladder: terminology and problem spectrum; References; Chapter 2 Pathophysiology; Introduction; The innervation of the bladder; The genesis of the NDO: three hypothesis; The link to the clinic; The neurological pathologies responsible for the development of the neurogenic bladder; Histological changes; Conclusions; References; Section 2 Evaluation; Chapter 3 Timing for evaluation; Conclusion; References
Chapter 4 Clinical evaluation Introduction; History; Neurological history; General gynecological history; Obstetric history; Other relevant past medical and surgical history; Drug history; Examination; Questionnaires and quality of life; Summary; References; Chapter 5 Urodynamic evaluation of the overactive bladder; Introduction; OAB and urodynamics; Filling cystometry and OAB; Cystometrogram; Does OAB equal urodynamic DO? A clinical correlation; Pressure-flow studies and OAB; Summary; References; Chapter 6 Other testing; Bladder/detrusor wall thickness; Biomarkers; Near infrared spectroscopy Bladder wall strain imaging Autonomic nervous system; Functional brain imaging; Conclusions; References; Section 3 First Line Management; Chapter 7 Changes in lifestyle; Introduction; Lifestyle modifications; Obesity; Smoking; Extremes of daily fluid intake; Dietary bladder irritants; Constipation and straining at stool; Summary; References; Patient Guide 1 Lifestyle changes that can improve bladder symptoms; Maintain a healthy weight; Stop smoking; Moderate liquid and beverage intake; Monitor your diet; Maintain bowel regularity; Chapter 8 Physical therapy; Physical therapy Scheduled voiding/bladder training Pelvic floor muscle training; Electrical stimulation; References; Section 4 Second Line Management; Chapter 9 Oral medication for overactive bladder; Introduction; Antimuscarinics; Beta 3 (β3) adrenergic receptor (AR) agonists; Antidepressants; References; Chapter 10 Patches and gels; Rationale for TD OXY delivery; Drug pharmacology; Conclusion/expert opinion; References; Chapter 11 Promising experimental drugs and drug targets; Introduction; P2X3-receptors and P2X3 receptor antagonists; The cannabinoid system; TRP channels; References Chapter 12 The role of co-medication in the treatment of OAB Introduction; Antimuscarinics and α-adrenoreceptor antagonists; Phosphodiesterase-5 inhibitors and α-adrenoreceptor antagonists; Other combination regimens; Future directions; References; Chapter 13 Other non-surgical approaches for the treatment of overactive bladder; Introduction; Bladder training; Acupuncture; Naturopathic and herbal remedies; Magnetic stimulation; Containment products; Future: tissue engineering and gene therapy; Conclusion; Abbreviations; Financial and competing interests disclosure; References Section 5 Third Line Management |
| Record Nr. | UNINA-9910809457303321 |
| Chichester, West Sussex, United Kingdom ; ; Hoboken, New Jersey : , : John Wiley & Sons, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||